SD Biosensor

SD Biosensor Intangible Assets

The Intangible Assets of SD Biosensor (137310.KS) as of Oct 21, 2026 is 723.12 B KRW. In the previous year, Intangible Assets was 728.68 B KRW — a change of -0.76% (lower).

Intangible Assets

723.12 BKRW

YoY

-0.76%

Last updated:

Intangible Assets of SD Biosensor is 2024 723.12 B KRW. Intangible Assets of SD Biosensor was 2023 728.68 B KRW. It decreases by -0.76% lower compared to the previous year.

The SD Biosensor Intangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Intangible Assets
Date
Intangible Assets
Jan 1, 2019
509.97 M KRW
Jan 1, 2020
650.57 M KRW
Jan 1, 2021
2.72 B KRW
Jan 1, 2022
23.37 B KRW
Jan 1, 2023
728.68 B KRW
Jan 1, 2024
723.12 B KRW
The SD Biosensor Intangible Assets history
YEARIntangible AssetsYoY
723.12 BKRW-0.76%
728.68 BKRW+3,018.54%
23.37 BKRW+757.93%
2.72 BKRW+318.64%
650.57 MKRW+27.57%
509.97 MKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SD Biosensor Stock analysis

What does SD Biosensor do? SD Biosensor Inc generates revenue through the development and manufacturing of cholesterol and blood glucose testing equipment. The company sells rapid immunochemical diagnosis products, immunochemical fluorescence diagnosis products, molecular diagnosis products, and enzyme immunological reaction diagnosis products. These products are distributed domestically and internationally, targeting healthcare providers and consumers in the immunochemical, molecular, and point-of-care diagnosis sectors. The firm focuses on self blood glucose measurement and other diagnostic solutions for medical use. The company's product portfolio includes POCTs, which are used for point-of-care testing in medical settings. SD Biosensor Inc's offerings serve both the domestic market and overseas markets, with a strong emphasis on diagnostic equipment for healthcare applications. Their business model relies on the sale of these specialized medical devices to hospitals, clinics, and individual consumers seeking home health monitoring solutions. Revenue streams are derived from the research, development, and sale of diagnostic products, including immunochemical and molecular diagnosis tools. The firm's products are designed for use in clinical and self-testing environments, supporting both professional healthcare services and personal health management. SD Biosensor Inc's market segments include healthcare institutions and end-users requiring diagnostic testing for cholesterol, blood glucose, and other medical conditions. SD Biosensor is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SD Biosensor stock

Intangible Assets of SD Biosensor is 723.12 B KRW in 2024.

Intangible Assets of SD Biosensor changed from 728.68 B KRW to 723.12 B KRW, representing a -0.76% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Intangible Assets SD Biosensor since 2006 – with annual values, charts, and detailed analysis.

Intangible assets are non-physical assets such as patents, trademarks, copyrights, and software. They can be significant value drivers for technology and pharmaceutical companies.

Intangible Assets's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Intangible Assets's SD Biosensor historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — SD Biosensor

All Key Metrics — SD Biosensor